Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model.
Antiviral Res. 2021 Sep;193:105126. doi: 10.1016/j.antiviral.2021.105126. Epub 2021 Jul 1.
Antiviral Res. 2021.
PMID: 34217753